Company

Genomic Vision propose des solutions fondées sur
l’analyse structurale de l’ADN et des tests génétiques
dans les domaines du cancer, des maladies héréditaires
rares et de la pharmaco-génomique.

 

Aaron Bensimon

Ph.D., co-founder, CEO & President

A Doctor of Molecular Biology, he founded Genomic Vision in 2004, before being appointed as CEO of the company in May 2006. He is also its scientific director.

Dr. Aaron Bensimon discovered the DNA "molecular combing" procedure. With unique expertise in this technology and how it is applied to molecular diagnostics, he has contributed significantly to the development of the discipline and published numerous articles in prestigious scientific journals (Science, Nature, Cell, etc.). He is the author of over twenty patent filings concerning molecular combing.

Before founding Genomic Vision, he spent 15 years as a researcher at the Pasteur Institute in Paris, where, from 1994, he directed the Genome Stability Unit. It was during his research in collaboration with the Laboratoire de Physique Statistique at the Ecole Normale Supérieure de Paris that he discovered the DNA molecular combing procedure.

In 1995, he received the Jacques Monod Award from the Fondation de France, which recognises young researchers who have made significant breakthroughs at the beginning of their careers.

From 1992 to 1993, he worked at the laboratory of Prof. Jean-Pierre Changeux (Pasteur Institute, Paris). His research focused on studying the myogenin gene's involvement in muscle denervation. This project was funded by the prestigious "Human Frontier Science Program" grant, obtained after earning his doctorate from the Weizmann Institute in Israel.

Aaron Bensimon has also undergone HEC "Challenge +" management training and regularly participates in scientific conferences.

 

frise

 

genomic_web_visuels_footer_COMPANY